Introduction
Human health risk assessments have tradi tionally relied heavily on toxicologic and other experimental data, but there is an increased recognition of the value of using epide miologic data in risk assessment. Previous publications (Fann et al. 2011; Jones et al. 2009; Lavelle et al. 2012; Vlaanderen et al. 2008) and initiatives have discussed how to improve the application of these epidemio logic data to risk assessments. As an example, at a meeting held in early 2010, the U.S. Environmental Protection Agency (EPA) requested input from the Federal Insecticide, Fungicide and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) on approaches for the "[i]ncorporation of epidemiology and human incident data into human health risk assessment [s] " (U.S. EPA 2009a). Epidemiologic studies play a key role in setting national ambient air quality standards (U.S. EPA 2009b) and contribute substan tially to other thematic weightofevidence approaches toward evaluating causality based on multiple lines of evidence (Rhomberg et al. 2010; Weed 2005) .
The incorporation of epidemiologic evidence into risk assessments is an impor tant part of understanding and characterizing risks from environmental and occupa tional exposures. Uncertainty arises from study limi tations regarding internal validity including exposure assessment, confounding and other potential sources of bias, and external validity or generali za tion from study populations to the populations for which risk assessments are conducted (Guzelian et al. 2005; Hertz Picciotto 1995; Lash et al. 2009; Levy 2008; Maldonado 2008; Persad and Cooper 2008) . Further, point estimates can be inaccurate because of internal validity issues and also because confidence intervals focus only on the potential for random error. These different sources of uncertainty can have an impact on various steps of the risk assessment paradigm (including hazard identification, exposure assessment, and dose-response assessment) resulting in hazards that are not recognized, hazards that are incorrectly identified, or inaccurate dose-response charac terizations that may lead to over or under estimation of "safe" exposure levels.
Epidemiologic approaches and statistical techniques exist to characterize uncertainty Background: There is a recognized need to improve the application of epidemiologic data in human health risk assessment especially for understanding and characterizing risks from environ mental and occupational exposures. Although there is uncertainty associated with the results of most epidemiologic studies, techniques exist to characterize uncertainty that can be applied to improve weightofevidence evaluations and risk characterization efforts.
Methods: This report derives from a Health and Environmental Sciences Institute (HESI) workshop held in Research Triangle
Park, North Carolina, to discuss the utility of using epide miologic data in risk assessments, including the use of advanced analytic methods to address sources of uncertainty. Epidemiologists, toxicologists, and risk assessors from academia, government, and industry convened to discuss uncertainty, exposure assessment, and application of analytic methods to address these challenges. synthesis: Several recommendations emerged to help improve the utility of epidemiologic data in risk assessment. For example, improved characterization of uncertainty is needed to allow risk asses sors to quantitatively assess potential sources of bias. Data are needed to facilitate this quantitative analysis, and inter disciplinary approaches will help ensure that sufficient information is collected for a thorough uncertainty evaluation. Advanced analytic methods and tools such as directed acyclic graphs (DAGs) and Bayesian statistical techniques can provide important insights and support interpretation of epidemiologic data. conclusions: The discussions and recommendations from this workshop demonstrate that there are practical steps that the scientific community can adopt to strengthen epidemiologic data for decision making. that can be applied to weightofevidence evaluations and risk characterization efforts. Although there is strong theoretical support for the utility of these approaches, their translation into regular epidemiologic practice is lagging. In addition, the impact of potential sources of error in epidemiologic studies is often only qualitatively discussed. For example, with respect to exposure measurement error, Jurek et al. (2006) sampled papers from three epide miology journals over 1 year and found that only 61% of the articles made any mention of exposure measurement error, and only 46% of those qualitatively described the possible effects. Only 1 of 57 sampled studies quanti fied the likely impact of exposure measurement error on results. This incomplete information demonstrates an opportunity among epide miologists to charac terize the magnitude and impact of various sources of uncertainty, which can help address one of the more difficult challenges in risk assessment.
This report derives from a workshop held in Research Triangle Park, North Carolina, in October 2012 (http://www.hesiglobal. org/i4a/pages/index.cfm?pageID=3641) to discuss the utility of using epidemiologic data in risk assessments, including the use of advanced analytic methods to address sources of uncertainty. The objective of the workshop was to develop recommendations on strengthening epidemiologic studies so that these data can more effectively be inte grated in risk assessments. The Health and Environmental Sciences Institute (HESI) workshop was focused specifically on uncer tainty, exposure assessment, and application of analytic methods to address these chal lenges. Crossdisciplinary experts in epidemi ology, toxicology, exposure assessment, and risk assessment attended the workshop. The delibera tions highlighted opportunities for epidemiologists to enhance scientific research in general and to address issues related to the development and use of epidemiologic data in risk assessment.
Uncertainty
The National Research Council (NRC 2009) defined uncertainty as the "lack or incom pleteness of information" critical for the risk assessment process. Uncertainty in an epide miologic study can arise from both random and systematic error in the study, whereas uncertainty in a risk assessment can arise from internal and external validity concerns arising from one study or set of studies included in the assessment. Thus, the characterization of scientific uncertainty can provide risk assess ments with a level of confidence regarding decisions that are being made and allows for evaluation of the degree that uncertainty plays in the analysis of consequences of specific policies. The NRC (2009) recommended that "risk assessments should characterize and communicate uncertainty and variability in all key computational steps of risk assess ments" while recognizing that "uncertainty analysis and characterization pose difficult technical issues, and in general related best practices have not been established." Thus, determining the nature and magnitude of uncertainties remains one of the key challenges in risk assessment.
Because results across epidemiologic, toxico logic, and clinical data may be dis cordant at times, there is a distinct need to under stand and charac terize sources of uncertainty within each of these areas to charac terize potential risk and hazard for risk assessment purposes. A comprehensive analysis of uncertainty across all data sources can act as a bridge to foster the integration neces sary to focus further research, improve risk assessment, and understand potential impacts on human health.
Uncertainty Issues and Recommendations
Improved charac teriza tion and discussion of plausible sources of uncertainty would be bene ficial in all epidemiologic reports and publica tions. The potential for bias in epidemiologic studies is routinely acknowledged in published reports but is nearly always limited to a qualita tive discussion (Jurek et al. 2006) . Even quan titative discussions of, for example, selection bias are typically limited to examinations of participation rates or to potential sampling bias due to selfselection. In addition, the poten tial for residual confounding by measured or unmeasured factors is often acknowledged, but the magnitude and direction are usually unknown or unstated. Thus, charac terizing and documenting the relationships (i.e., the direction and magnitude of associations) among potential confounders, exposures, and outcomes of interest is critical. Knowing the direction of a potential confounder (e.g., positive vs. negative confounding) could enable epidemiologic data to be used in the hazard identification stage of a risk assessment or for dose-response assessments if the magnitude of confounding is also known or the uncertainty from this source of bias could be quantified. Addressing these possible sources of bias in an epidemiologic study may allow risk assessors, to the extent possible, to quantify the conse quences of any bias in a specific study or across a group of similar studies. Although not a type of bias, an additional source of uncertainty is related to generalizing study results beyond the sample population being examined in an epidemiologic study. Characterizing variability in risk among different susceptible populations will ultimately make results of epidemiologic studies more relevant to risk assessment efforts and risk management decision making.
Conduct more validation studies and uncertainty analyses of epidemiologic study findings. The overall impact of different sources of uncertainty on epidemiologic results is infrequently considered in epidemiologic publications, and data sufficient to allow the reader to undertake independent uncertainty assessments are often not presented (Jurek et al. 2007) . This is essentially the lowest tier (i.e., tier 0) of uncertainty analyses recognized by the NRC (2009) We therefore recommend that investiga tors obtain additional data needed to facili tate uncertainty analysis and undertake at least a qualitative assessment of uncertainty, including all recognized sources or justifying their omission. A qualitative charac terization would include identifying possible sources and beginning to assess the sources, direction, and magnitude of uncertainty. The potential rami fications of each source of uncertainty should be addressed and some crude classification or categorization approaches could be developed (e.g., low, intermediate, or high uncertainty) with respect to a given source. When sources of uncertainty can be identified but not fully quantified within a study or set of studies, there may be default data available that can be useful in estimating a possible range of values (Stürmer et al. 2007 ). Indeed, there may also be a complete lack of data that contribute to the uncertainty. However, investigators could consider the direction and magnitude of the potential uncertainty (i.e., confounding and/or bias). Such data would allow for higher tiers of uncertainty analyses. Methodologic guidance and software for quantitative bias analysis have also become available (Lash et al. 2009) but are not yet common in risk assessment. Ideally, to facilitate the highest tier of uncertainty analysis, a quantitative assess ment of individual and conjoint sources of uncertainty would be included in every epide miologic study. The conduct of more vali dation studies and sensitivity analyses is also recommended to better understand methodo logical issues and sources of uncertainty (Chatterjee and Wacholder 2002; Greenland 1996; Rosenbaum 2005; Schneeweiss 2006; VanderWeele and Arah 2011) .
Improve communication about epide mio logic uncertainty. We encourage full disclosure of uncertainty in epidemiology as a matter of transparency. Characterization and volume 122 | number 11 | November 2014 • Environmental Health Perspectives quantification of uncertainty should increase such that the basis of decisions and assump tions are clear, either within the publication or in supplemental information. Epidemiologists and their peer scientists should encourage publications and other communications to include the necessary studyspecific data on internal data relationships relevant to selec tion bias, information bias, and confounding for quantitative bias analysis to assess uncertainty (Lash et al. 2009 ). Reviewers of manuscripts should also recommend qualita tive, and if possible quantitative, discussions of uncertainties. The objective is for such information to be more routinely collected and reported.
Develop a broader matrix of sources of uncertainty for the overall risk assessment process, with the goal of harmonization of uncertainty assessment across different disciplines. Risk assessments consider the totality of the evidence (i.e., epidemiology, toxicology, and other lines of scientific evidence, as well as any other knowledge in the context of risk) when determining the weight of evidence. Other lines of evidence such as toxicology and mode of action can be used to inform the interpretation and use of epidemio logic data in risk assessment. Because uncer tainties exist in all lines of scientific endeavor, each source of uncertainty across these areas should be considered in assessing uncertainty in the overall risk assessment. Previous efforts have recommended harmonization of the incorporation of uncertainty in risk assess ment, primarily focusing on the use of default uncertainty values from toxico logic data (SonichMullin et al. 2001) . Consequently, harmonization of sources of uncertainty across epidemiology and toxicology should be under taken in a systematic manner that will make for more transparent decision making.
Exposure Assessment
Exposure science aims to quantify the inten sity, frequency, duration, and timing of human contact with chemical, physical, or biological agents occurring in the environment, and may be used to further inform evaluation of causality in the environmental sourcetohealth outcome continuum (Barr 2006) . Within exposure science, exposure assessment specifi cally deals with several distinct aspects that underlie the risk assessment process, including exposure source(s), environ mental pathway(s), environ mental concentrations, human exposures, and dose.
Data are rarely available on biologically relevant dose metrics (e.g., absorbed dose, effective dose) in the organ or tissue of interest in epidemiologic studies; thus, dose is often estimated indirectly using exposure metrics. These surrogate estimates of exposure are subject to measurement error because they may rely on imperfectly measured concen trations in the individual, or on models of transport and fate in the environment or workplace. In addition, measurement error may result from estimates of the distribution of human uptake over time (e.g., use of a physiologically based pharmaco kinetic model) or collection of activity pattern data.
Similar to measurement error and the resulting misclassification of health outcome data, exposure misclassification is important to characterize in epidemiologic studies because it can distort exposure-response relation ships and lead to biased or imprecise results. Exposure measurement error can be differen tial or non differential with respect to variation in disease status. Exposure measurement error can lead to exposure misclassification when exposure surrogates for individual participants are classified into categories for analysis.
Differential misclassification can arise in categorical exposure metrics even when there is non differential error (i.e., independent of disease status) in an exposure variable that is measured on a continuous scale (Flegal et al. 1991) . For epidemiologic studies to be evaluated and used appropriately in risk assessment, it is important that exposure measurement error is characterized and evalu ated thoroughly with considera tion of the magnitude and direction of any potential exposure misclassification bias (Bergen et al. 2013 ). This information is useful for risk assessors when they evaluate the potential for bias and confidence placed on study results.
Exposure Assessment Issues and Recommendations
An interdisciplinary perspective is needed during the studydesign phase to ensure that biologically relevant quantitative exposureresponse information is collected that will be useful for risk assessment purposes. During the studydesign phase, an inter disciplinary team including experts-for example, in epidemi ology, exposure assessment, industrial hygiene, and analytical chemistry-should be assem bled to develop robust exposure assessment approaches. This might include considera tion of targeted data collection strategies, such as collection of exposure or surrogate data based on the appropriate biological matrix, sample number, and the critical exposure window(s). Other constraints that can be addressed include sources of exposure variability, avail ability of resources, participant burden, and ethical considerations (with institutional review board review as appropriate). This inter disciplinary approach will allow for the collection of biologically relevant exposure data to increase the potential for quantifica tion of exposure-response relationships that will be useful for risk assessment and risk management purposes.
Develop exposure assessment approaches that are transparent and well characterized.
We recommend that study authors should discuss the nature (i.e., type, direction, and magnitude) and likelihood of any expected exposure measurement error and misclassi fication bias. An evaluation of measurement error and any resulting impact on effect estimates would provide risk assessors with information to weight studies by the quality of the exposure assessment, the methods used to adjust for exposure measurement error, and the likelihood that exposure measure ment error contributes to uncertainty in effect estimates in epidemiologic studies. Characterization of exposure data quality may include steps to make exposure data publicly available so that risk assessors can perform secondary data analyses including sensitivity and uncertainty analyses.
Quantify exposure measurement error and examine and correct for its impact on effect estimates. Ignoring uncertainty in exposure estimation can produce bias when such esti mates are used to examine associations with adverse health effects (Carroll et al. 1995) . Although epidemiologic publications infre quently present detailed information on the potential impact of measurement error (Jurek et al. 2006; Spiegelman 2010) , epidemiologic study results would be enhanced by detailing exposure assessment assumptions and charac terizing measurement error to allow risk assessors to gauge the potential impact of this error. This information should include charac terization of different sources and types of measurement error. The sources and types can be based on various assumptions used in exposure modeling efforts, including unac counted inter and intra individual variability in exposure patterns (Kromhout et al. 1993; Symanski et al. 2007) or from variability based on limited monitoring data. Once these different types and sources of measurement error are identified, bias analyses should be included to examine uncertainty due to the use of different exposure metrics in relation to what is known about the critical exposure period or evalua tion of specific parame ter estimates (e.g., halflife considerations of biological measures) or other modeling assumptions, such as the validity of the under lying input data (e.g., chemical moni toring data) and modeling data (e.g., fate and transport models) used to estimate exposure concentrations. Statistical techniques, both nonBayesian and Bayesian, are available to allow for the correction of biased effect esti mates resulting from exposure measurement error. Examples of nonBayesian methods for accounting and adjusting for exposure measurement error include conditional likeli hood methods (Guolo and (Spiegelman 2010 ) and conditional scores procedures (McShane et al. 2001) , whereas Bayesian methods exist that can be used for both binary and continuous exposures (EspinoHernandez et al. 2011; Liu et al. 2009; Prescott and Garthwaite 2005; Rice 2003) .
Develop improved methods for assessing exposures to multiple environmental chemicals and multiple routes of exposure. Traditionally, risk assessments have focused primarily on single chemicals. However, this does not reflect human exposure conditions. There is a recognized need to focus on multi media sources of exposure to individual chemicals as well as complex mixtures. This is an area of research where observational studies, such as epidemiology, are an improvement over experi mental studies because they can more readily address multiple exposures simultaneously.
It is important that epidemiologists continue to develop and evaluate methods for assessing exposure to complex mixtures in order to better characterize exposure assess ment and to allow for the evaluation of effect measure modification and confounding. This would establish a robust scientific database necessary to conduct cumulative risk assessments. The understanding of the relationships among complex exposures will require modeling of monitoring data and other exposure determinants and develop ment of techniques for assessing exposures to mixtures that result in unbiased or minimally biased effect estimates (Carlin et al. 2013 ). In addition, approaches such as multi variate source receptor modeling represent promising avenues for assessing exposure to complex mixtures (Hopke 2010) , although further work is needed to account for key sources of uncertainty in such models. The develop ment of efficient, easily measured, costeffective exposure surrogates for key mixtures of concern will be important, and will include its own challenges for identifying and quantifying exposure measurement error. For example, it will be important to understand how the type and structure of measure ment error may differ across different individual mixture compo nents or for a surrogate representing exposure to the whole mixture. Techniques are needed to charac terize and adjust for exposure measurement error of chemical mixtures.
Analytic Tools in Epidemiology
Given that epidemiologic data are key inputs for risk assessments, it is important to apply methodologies that better charac terize validity and precision of study results. The methods considered can be broadly clas sified as a) frequentist methods to address study biases systematically and quantitatively; b) Bayesian statistical techniques, which utilize prior knowledge addressing causal hypotheses and estimation problems under evaluation; and c) computational methods (e.g., crossvalidation, resampling tech niques, and boosting and model ensemble techniques), which provide valid statistical inferences without requiring strong a priori modeling assumptions. Each of these broad approaches addresses validity and charac terizes the uncertainty of results from a single study and extends to improved charac teriza tion of epidemiologic results in weightof evidence assessments.
The analytic methods group discussion included four specific areas that facilitate causal interpretation in epidemiology: a) the use of directed acyclic graphs [DAGs, diagrams consisting of variables connected by arrows or lines to depict often complex relationships (Joffe et al. 2012) ]; b) summarizing epidemio logic results using Bayesian posterior distribu tions; c) strategies for quantitatively evaluating measurement error; and d) formally assessing causality as it relates to policy decisions. Each of these areas led to a set of recommendations. These areas served as the basis for further discussion of related topics such as primary versus secondary analyses, journal require ments, epidemiology curricula, and data sharing practices.
Analytic Methods: Issues and Recommendations
The application of DAGs should be encouraged more broadly. Joffe et al. (2012) described how DAGs make explicit the assumed or estimated relationships among unobserved and measured variables, indicating the causal direction of the potential relationships. As described, DAGs are considered to be an appropriate method to illustrate causal hypotheses and to specify the structure of associations between variables of interest. They also provide a useful way to represent assumptions, especially conditional independence assumptions, necessary for statistical analyses and causal inference. Last, DAGs are helpful for determining which factors may be confounders or effect modi fiers of an association between exposure and outcome (VanderWeele and Robins 2007). DAGs provide transparent representations of a hypothesis as well as justification for specific analytic strategies to be applied during the investigation, such as identification of causal intermediates. DAGs can also clarify methodo logic challenges, such as illustrating selection bias (Flanders and Klein 2007; Hernán et al. 2004) . We recommend that journal editors request that DAGs be included in supplemental material (Westreich and Greenland 2013) .
Incorporate prior knowledge through Bayesian methods. Bayesian statistical analysis differs from frequentist methods in that Bayesian analyses use information that exists before study data are collected and analyzed (i.e., "prior" distributions) to update what can be learned about a specific problem after conducting a study by expressing the new state of knowledge as "posterior" distribu tions. Results from the literature or other data sources are used to specify the a priori distri bution for any parameters, such as the size and direction of exposure-outcome associa tions and the extent of measurement error. Subsequently, the study results generated by the analysis provide an assessment of the conditional probability distribution of param eters of interest (the posterior distribution) by reconciling the data observed, the analytic model fitted to the study data, and the prior information incorporated into the analytic model (Bolstad 2007) .
Bayesian techniques can also allow for simultaneous correction for sources of bias such as measurement error and confounding (de Vocht et al. 2009; Steenland and Greenland 2004 ) that are typically treated in isolation in current practice of epidemiology (Gustafson and McCandless 2010) . Although these techniques are not routinely employed, specification of prior model probabilities by investigators is inherent in grant proposals, the introduction section of a study publica tion, and the subjective interpretation of results (Goodman 2001) . Thus, it could be argued that current practice involves presenting Bayesian considerations of a research article, whereas the reported results often rely on frequentist analysis and qualitative interpretations (Pearce and Corbin 2013) .
Measurement error should not be ignored in any analysis of epidemiologic results and should be assessed using quantitative methods. Measurement error is an almost universal limitation of epidemiologic studies and their analyses. The current practice of acknowl edging it diffusely with a brief discussion that frequently invokes its theoretical impact, for example, that it is most likely to be non differential and results in potential for bias toward a null result, will not improve epide miologic input into risk assessments. Strategies for quantitatively correcting for the bias resulting from measurement error are described in textbooks and can be readily implemented for many study designs. These include regres sion calibration, simulation-extrapolation, Bayesian approaches (Carroll et al. 1995; Gustafson 2004) , and computational statistical approaches (e.g., multiple imputations, data augmentation, and expectation-maximization algorithms). Attention should be given to correcting for measurement error available in commonly used epidemiologic software plat forms such as rcal in STATA (http://www. stata.com/merror/rcal.pdf) (Hardin et al. 2003) or PROC CALIS in SAS (SAS Institute volume 122 | number 11 | November 2014 • Environmental Health Perspectives Inc.). Peer reviewers and journal editors should expect formal quantitative assessments of measurement error and related biases, as well as correction for bias created by measurement error, rather than relying on qualitative discus sions. In addition, adequate funding should be designated for exposure validation studies, and granting agencies should consider such vali dation studies as essential criteria for funding epidemiologic research (Heid et al. 2004) .
Distinguish associations from causes. Formal causality assessments are important and influence policy decisions. The synthesis of epidemiologic studies can be the primary basis for regulation and policy actions. Without stateoftheart analytic techniques being used more routinely in epidemiologic studies and other lines of evidence, the benefits and costs of recommended inter ventions or action could be mis estimated and apparent costeffective interventions may be ineffective. In particu lar, it is unwarranted to assume that a specific statistical association represents a causal effect, such that changing the predictor variable would result in a corresponding change in the outcome variable (Freedman 2004) . Indeed, the distinction between structural and reducedform equations in econometrics, and phenomena such as Simpson's Paradox, demonstrate that (reducedform) regression coefficients need not even have the same sign as corresponding causal coefficients, showing how a change in an explanatory variable would change the dependent variable (Pearl 2009) .
Although epidemiologists are aware of basic threats to inferential validity from observa tional studies, there is little agree ment, even among workshop participants, on whether epidemiologists should consider the policy implications of declaring an association to be causal. One view expressed by workshop participants was that epidemiologists should primarily conduct research that supports or refutes qualitative statements about causa tion, as in showing that an exposure "causes" a specific disease. This viewpoint emphasizes epidemiology's role in hazard identification, that is, an early stage of risk assessment for which putative threats to health are identi fied as causal. Another viewpoint was that epidemiologic results could be used to concep tualize causation in the context of popula tion health, for example, showing that some modifiable exposure is capable of causing important changes in health of popula tion overall. This would more closely align epidemiology with the risk characterization phase of risk assessment in which costs and benefits of risk management interventions are weighted and risks are appraised quanti tatively (Phillips 2001) . Alternative outcomes analysis, an example of a technique that can provide important insights in distinguishing association from causation, could be more routinely applied in assessing causal infer ence and attributable risk estimation (Jager et al. 1990; Meijster et al. 2011a Meijster et al. , 2011b Thomsen et al. 2006) . Alternative outcomes analysis allows for the conceptualization of causation in terms of causes of meaningful versus ignorable consequences, assuming these can be readily differentiated into one of these two options. Regardless of how epidemiologic data align with the risk assessment paradigm, epidemiologic practice should adopt methods that apply stateoftheart techniques to address uncertainty and other study limita tions and to help contextualize epidemiologic study results in terms of causality and public health intervention.
Conclusions and Future Directions
Epidemiologic data are critical for risk assess ment efforts but are rarely conducted with quantification of uncertainty, which may limit their use in risk assessments. The HESI Epidemiology Subcommittee workshop focused on strengthening the utility and application of epidemiology studies by recom mending improvements in analytic methods, exposure assessment approaches, and other techniques to quantify and account for specific sources of uncertainty.
Several recommendations resulted from this effort. Specific statistical approaches and analytic techniques, such as increased use of quantitative bias analysis, DAGs, and Bayesian analyses, are available for improving the infer ences drawn from epidemiologic results and are currently used infrequently. In addition, new methods may be needed for assessing exposure and charac terizing uncertainty related to chemical mixtures. Other deliberations in the workshop highlighted the complete reporting of all data elements and analytic tables to permit others to conduct uncertainty analyses (either in supplemental material published by journals or through the inves tigators' institution). Specifically, increased transparency of results would improve weight ofevidence evaluations, and collaboration with researchers in other disciplines would improve study designs and analytic approaches, particularly for exposure assessment.
Although there are multiple strategies for quantifying and reducing measurement error, there are barriers for routinely applying these techniques. A key disincentive is that substan tial time and effort can be required to conduct validation or reliability studies, which can put a strain on research budgets. There may also be a perception that analyses of exposure measurement error tends to decrease the esti mated precision of reported results, thereby increasing the probability of a falsenegative result (Blair et al. 2009 ). Blair et al. (2007) suggested that exposure measurement error and the resulting misclassi fication is more likely to be non differential by disease status in epidemiology studies and will most frequently result in false negatives through attenuation of effect estimates. This assumption is made despite evidence from statistical literature that the impact of exposure measurement error can be profound and complex and that it is diffi cult to anticipate its impact on effect estimates in an individual study (Gustafson 2004) . Given that many manuscripts are routinely accepted without analyses quantifying uncer tainty, validated exposure assessment, or use of advanced analytic methods, there is little incentive to adopt the recommendations made. Funding organizations, peer reviewers, and journal editors should be catalysts for change in this effort.
The discussions and recommendations from this workshop demonstrate that there are practical steps that the scientific community can adopt to strengthen epidemiologic data for decision making. Use of available methods to quantify and adjust for uncertainty will help reduce the potential impact of different sources of error and bias and help achieve better decisions for risk assessment, policy, and ultimately public health.
